Works matching IS 14642662 AND DT 2014 AND VI 15 AND IP 7

Results: 8

Helping our patients take HIV pre-exposure prophylaxis ( PrEP): a systematic review of adherence interventions.

Published in:

HIV Medicine, 2014, v. 15, n. 7, p. 385, doi. 10.1111/hiv.12132

By:

Marcus, JL;
Buisker, T;
Horvath, T;
Amico, KR;
Fuchs, JD;
Buchbinder, SP;
Grant, RM;
Liu, AY

Publication type:

Article

The significance of low-level viraemia in diverse settings: analysis of the Treat Asia HIV Observational Database ( TAHOD) and the Australian HIV Observational Database ( AHOD)

Published in:

2014

By:

Kanapathipillai, R;
McManus, H;
Cuong, Dd;
Ng, Ot;
Kinh, Nv;
Giles, M;
Read, T;
Woolley, I

Publication type:

Journal Article

European mitochondrial haplogroups are not associated with hepatitis C virus ( HCV) treatment response in HIV/ HCV-coinfected patients.

Published in:

HIV Medicine, 2014, v. 15, n. 7, p. 425, doi. 10.1111/hiv.12126

By:

Guzmán‐Fulgencio, M;
Rallón, N;
Berenguer, J;
Fernández‐Rodríguez, A;
Soriano, V;
Miralles, P;
Jiménez‐Sousa, MA;
Restrepo, C;
López, JC;
García‐Álvarez, M;
Aldámiz, T;
Benito, JM;
Resino, S

Publication type:

Article

Patients who present late to HIV care and associated risk factors in Nigeria.

Published in:

HIV Medicine, 2014, v. 15, n. 7, p. 396, doi. 10.1111/hiv.12125

By:

Agaba, PA;
Meloni, ST;
Sule, HM;
Agbaji, OO;
Ekeh, PN;
Job, GC;
Nyango, N;
Ugoagwu, PO;
Imade, GE;
Idoko, JA;
Kanki, PJ

Publication type:

Article

Efficacy and safety of once-daily maraviroc plus ritonavir-boosted darunavir in pretreated HIV-infected patients in a real-life setting.

Published in:

HIV Medicine, 2014, v. 15, n. 7, p. 417, doi. 10.1111/hiv.12129

By:

Macías, J;
Recio, E;
Márquez, M;
García, C;
Jiménez, P;
Merino, D;
Muñoz, L;
Pasquau, J;
Ojeda, G;
Bancalero, P;
Chueca, N;
Pineda, JA

Publication type:

Article

The significance of low-level viraemia in diverse settings: analysis of the Treat Asia HIV Observational Database ( TAHOD) and the Australian HIV Observational Database ( AHOD).

Published in:

HIV Medicine, 2014, v. 15, n. 7, p. 406, doi. 10.1111/hiv.12124

By:

Kanapathipillai, R;
McManus, H;
Cuong, DD;
Ng, OT;
Kinh, NV;
Giles, M;
Read, T;
Woolley, I

Publication type:

Article

Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial.

Published in:

HIV Medicine, 2014, v. 15, n. 7, p. 431, doi. 10.1111/hiv.12128

By:

Lake, JE;
McComsey, GA;
Hulgan, T;
Wanke, CA;
Mangili, A;
Walmsley, SL;
Stramotas, SA;
Tracy, R;
Currier, JS

Publication type:

Article

A comparison of computational models with and without genotyping for prediction of response to second-line HIV therapy.

Published in:

HIV Medicine, 2014, v. 15, n. 7, p. 442, doi. 10.1111/hiv.12156

By:

Revell, AD;
Boyd, MA;
Wang, D;
Emery, S;
Gazzard, B;
Reiss, P;
Sighem, AI;
Montaner, JS;
Lane, HC;
Larder, BA

Publication type:

Article